Northpond Ventures, LLC
- SEC CIK
- 0001911245
- Latest filing
- Nov 14, 2024
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 1, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 5
- 0 vs. Q1 2022
- Portfolio value
- $105.0M
- −$80.6M (−43.4%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DICEDICE Therapeutics, Inc. | COM | 3,292,871 | $51.1M | 48.7% | 00.0% | Unchanged | History |
| ISOIsoPlexis Corp | COM | 8,808,531 | $19.0M | 18.1% | 00.0% | Unchanged | History |
| TBIOTelesis Bio Inc. | COM | 9,844,130 | $17.7M | 16.9% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 4,214,498 | $10.9M | 10.4% | 00.0% | Unchanged | History |
| CADLCandel Therapeutics, Inc. | COM | 1,935,215 | $6.27M | 6.0% | 00.0% | Unchanged | History |